Right ventricular myocardial infarction: Difference between revisions
Rim Halaby (talk | contribs) No edit summary |
|||
(16 intermediate revisions by 4 users not shown) | |||
Line 1: | Line 1: | ||
{ | __NOTOC__ | ||
{| class="infobox" style="float:right;" | |||
|- | |||
| [[File:Siren.gif|30px|link=Right ventricular myocardial infarction resident survival guide]]|| <br> || <br> | |||
| [[Right ventricular myocardial infarction resident survival guide|'''Resident'''<br>'''Survival'''<br>'''Guide''']] | |||
|} | |||
{{Right ventricular myocardial infarction}} | |||
}} | |||
{{ | '''For patient information click [[Heart attack (patient information)|here]]''' | ||
{{CMG}}; '''Associate Editor-In-Chief:''' {{CZ}}; [[Priyamvada Singh|Priyamvada Singh, M.D.]] [mailto:psingh13579@gmail.com] | |||
==[[Right ventricular myocardial infarction overview|Overview]]== | ==[[Right ventricular myocardial infarction overview|Overview]]== | ||
== [[ST elevation myocardial infarction pathophysiology|Pathophysiology]] == | == [[ST elevation myocardial infarction pathophysiology|Pathophysiology]] == | ||
[[ST Elevation Myocardial Infarction: Pathophysiology of Reperfusion|Pathophysiology of Reperfusion]] | [[ST elevation myocardial infarction gross pathology|Gross Pathology]] | [[ST elevation myocardial infarction histopathology|Histopathology]] | |||
==[[Right ventricular myocardial infarction causes|Causes]]== | |||
==[[Right ventricular myocardial infarction differential diagnosis|Differentiating Right ventricular myocardial infarction from other Diseases]]== | ==[[Right ventricular myocardial infarction differential diagnosis|Differentiating Right ventricular myocardial infarction from other Diseases]]== | ||
== [[ST elevation myocardial infarction epidemiology and demographics|Epidemiology and Demographics]] == | == [[ST elevation myocardial infarction epidemiology and demographics|Epidemiology and Demographics]] == | ||
Line 30: | Line 24: | ||
== [[ST elevation myocardial infarction risk factors|Risk Factors]] == | == [[ST elevation myocardial infarction risk factors|Risk Factors]] == | ||
==[[Right ventricular myocardial infarction natural history|Natural History, Complications | ==[[Right ventricular myocardial infarction natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | ||
==Diagnosis== | ==Diagnosis== | ||
[[Right ventricular myocardial infarction diagnostic criteria|Diagnostic Criteria]] | [[Right ventricular myocardial infarction history and symptoms|History | [[Right ventricular myocardial infarction diagnostic criteria|Diagnostic Criteria]] | [[Right ventricular myocardial infarction history and symptoms|History and Symptoms]] | [[Right ventricular myocardial infarction physical examination|Physical Examination]] | [[Right ventricular myocardial infarction electrocardiogram|Electrocardiogram]] | [[Right ventricular myocardial infarction chest x ray|Chest X Ray]] | [[Right ventricular myocardial infarction echocardiography or ultrasound|Echocardiography or Ultrasound]] | [[ST elevation myocardial infarction coronary angiography|Coronary Angiography]] | [[Right ventricular myocardial infarction other imaging findings|Other Imaging Findings]] | ||
==Treatment== | ==Treatment== | ||
====[[Right ventricular myocardial infarction initial care|Initial Care]]==== | |||
'''Pharmacologic Reperfusion''' | '''Pharmacologic Reperfusion''': [[ST elevation myocardial infarction reperfusion therapy|Reperfusion Therapy (Overview of Fibrinolysis and Primary PCI)]] | [[ST elevation myocardial infarction fibrinolytic therapy|Fibrinolysis]] | ||
'''Mechanical Reperfusion''' | '''Mechanical Reperfusion''': [[Door-to-Balloon|The Importance of Reducing Door-to-Balloon Times]] | [[ST elevation myocardial infarction primary percutaneous coronary intervention|Primary PCI]] | [[ST elevation myocardial infarction percutaneous coronary intervention following fibrinolytic administration|Adjunctive and Rescue PCI]] | [[ST elevation myocardial infarction rescue percutaneous coronary intervention|Rescue PCI]] | | ||
[[ST elevation myocardial infarction facilitated percutaneous coronary intervention|Facilitated PCI]] | | [[ST elevation myocardial infarction facilitated percutaneous coronary intervention|Facilitated PCI]] | | ||
[[ST Elevation Myocardial Infarction Adjunctive Percutaneous Coronary Intervention|Adjunctive PCI]] | | [[ST Elevation Myocardial Infarction Adjunctive Percutaneous Coronary Intervention|Adjunctive PCI]] | | ||
[[ST elevation myocardial infarction coronary artery bypass grafting|CABG]] | [[ST elevation myocardial infarction management of patients who were not reperfused|Management of Patients Who Were Not Reperfused]] | [[ST elevation myocardial infarction assessing success of reperfusion|Assessing Success of Reperfusion]] | [[ST elevation myocardial infarction coronary artery bypass grafting|CABG]] | [[ST elevation myocardial infarction management of patients who were not reperfused|Management of Patients Who Were Not Reperfused]] | [[ST elevation myocardial infarction assessing success of reperfusion|Assessing Success of Reperfusion]] | ||
'''Antithrombin Therapy''' | '''Antithrombin Therapy''': [[ST elevation myocardial infarction anticoagulant and antithrombotic therapy|Antithrombin Therapy]] | [[ST elevation myocardial infarction anticoagulant and antithrombotic therapy#Unfractionated Heparin|Unfractionated Heparin]] | [[ST elevation myocardial infarction anticoagulant and antithrombotic therapy#Enoxaparin|Low Molecular Weight Heparinoid Therapy]] | [[ST elevation myocardial infarction anticoagulant and antithrombotic therapy#Bivalirudin|Direct Thrombin Inhibitor Therapy]] | [[ST elevation myocardial infarction anticoagulant and antithrombotic therapy#Fondaparinux|Factor Xa Inhibition]] | [[ST elevation myocardial infarction deep vein thrombosis prophylaxis and anticoagulation|DVT Prophylaxis]] | [[ST elevation myocardial infarction deep vein thrombosis prophylaxis and anticoagulation|Long Term Anticoagulation]] | ||
'''Antiplatelet Agents''' | '''Antiplatelet Agents''': [[ST elevation myocardial infarction aspirin therapy|Aspirin]] | [[ST elevation myocardial infarction thienopyridine therapy|Thienopyridine Therapy]] | [[ST elevation myocardial infarction glycoprotein IIbIIIa inhibition|Glycoprotein IIbIIIa Inhibition]] | ||
'''Other Initial Therapy''' | '''Other Initial Therapy''': [[ST elevation myocardial infarction inhibition of the renin-angiotensin-aldosterone system at discharge|Inhibition of the Renin-Angiotensin-Aldosterone System]] | [[ST elevation myocardial infarction magnesium therapy|Magnesium Therapy]] | [[ST elevation myocardial infarction glucose control|Glucose Control]] | [[ST elevation myocardial infarction calcium channel blocker therapy|Calcium Channel Blocker Therapy]] | ||
[[Category:Cardiology]] | [[Category:Cardiology]] |
Latest revision as of 14:58, 17 March 2014
Resident Survival Guide |
Right ventricular myocardial infarction Microchapters |
Differentiating Right ventricular myocardial infarction from other Diseases |
---|
Diagnosis |
Treatment |
Pharmacological Reperfusion |
Mechanical Reperfusion |
Antithrombin Therapy |
Antiplatelet Agents |
Other Initial Therapy |
Right ventricular myocardial infarction On the Web |
Directions to Hospitals Treating Right ventricular myocardial infarction |
Risk calculators and risk factors for Right ventricular myocardial infarction |
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Priyamvada Singh, M.D. [3]
Overview
Pathophysiology
Pathophysiology of Reperfusion | Gross Pathology | Histopathology
Causes
Differentiating Right ventricular myocardial infarction from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria | History and Symptoms | Physical Examination | Electrocardiogram | Chest X Ray | Echocardiography or Ultrasound | Coronary Angiography | Other Imaging Findings
Treatment
Initial Care
Pharmacologic Reperfusion: Reperfusion Therapy (Overview of Fibrinolysis and Primary PCI) | Fibrinolysis
Mechanical Reperfusion: The Importance of Reducing Door-to-Balloon Times | Primary PCI | Adjunctive and Rescue PCI | Rescue PCI | Facilitated PCI | Adjunctive PCI | CABG | Management of Patients Who Were Not Reperfused | Assessing Success of Reperfusion
Antithrombin Therapy: Antithrombin Therapy | Unfractionated Heparin | Low Molecular Weight Heparinoid Therapy | Direct Thrombin Inhibitor Therapy | Factor Xa Inhibition | DVT Prophylaxis | Long Term Anticoagulation
Antiplatelet Agents: Aspirin | Thienopyridine Therapy | Glycoprotein IIbIIIa Inhibition
Other Initial Therapy: Inhibition of the Renin-Angiotensin-Aldosterone System | Magnesium Therapy | Glucose Control | Calcium Channel Blocker Therapy